Forahale 200 Inha Caps is a combination medication containing Formoterol (6 mcg) and Budesonide (200 mcg) designed for the management of asthma and chronic obstructive pulmonary disease (COPD). Formoterol is a long-acting beta2-adrenergic agonist that helps relax the muscles in the airways, facilitating easier breathing by preventing bronchospasm. Budesonide is a corticosteroid that reduces inflammation and swelling in the airways, thereby improving airflow and decreasing the frequency and severity of asthma attacks. This dual-action inhalation capsule provides both immediate bronchodilation and long-term control of airway inflammation, making it effective for patients requiring maintenance therapy. Forahale 200 Inha Caps are typically used twice daily as prescribed by a healthcare professional, and consistent use is essential for optimal control of respiratory symptoms. It is important to use this medication regularly, even when symptoms are not present, to prevent exacerbations. Patients should be advised on proper inhalation technique to ensure maximum drug delivery to the lungs. Common side effects may include throat irritation, hoarseness, or oral candidiasis, which can be minimized by rinsing the mouth after use. Forahale 200 Inha Caps should be used under medical supervision, especially in patients with cardiovascular disorders or hypersensitivity to its components.